Elisabeth Granström
- Pharmacology top 0.2%
- Physiology top 1%
- Molecular Biology top 5%
- Biochemistry top 0.2%
- Genetics top 5%
- Co-authors
- Bengt SamuelssonH. KindahlMats HámbergSven HammarströmCurt MalmstenMarc E. GoldyneSven‐Erik DahlénMaria Kumlin
- Topics
- Inflammatory mediators and NSAID effects (51 papers)Eicosanoids and Hypertension Pharmacology (23 papers)Antiplatelet Therapy and Cardiovascular Diseases (11 papers)
- Cited by
- BiochemistryPharmacologyEquine
- Journals
- Proceedings of the National Academy of SciencesJournal of the American Chemical SocietyJournal of Biological Chemistry
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Elisabeth Granström
104 papers receiving 5.4k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Pharmacology 2.2k
- Physiology 1.3k
- Molecular Biology 1.3k
- Biochemistry 1.1k
- Genetics 671
Countries citing papers authored by Elisabeth Granström
This map shows the geographic impact of Elisabeth Granström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Granström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Granström more than expected).
Fields of papers citing papers by Elisabeth Granström
This network shows the impact of papers produced by Elisabeth Granström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Granström. The network helps show where Elisabeth Granström may publish in the future.
Co-authorship network of co-authors of Elisabeth Granström
This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Granström. A scholar is included among the top collaborators of Elisabeth Granström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Granström. Elisabeth Granström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 53 | |
| 2 | 27 | |
| 3 | 33 | |
| 4 | 5 | |
| 5 | 5 | |
| 6 | 23 | |
| 7 | 16 | |
| 8 | 9 | |
| 9 | 238 | |
| 10 | 94 | |
| 11 | 15(S)-hydroxyeicosatetraenoic acid (15-HETE) is the major arachidonic acid metabolite in human bronchi. | 7 |
| 12 | 21 | |
| 13 | 2 | |
| 14 | Assay of thromboxane production in biological systems: reliability of TXB2 versus 11-dehydro-TXB2 as targets for measurement. | 4 |
| 15 | 16 | |
| 16 | 44 | |
| 17 | 28 | |
| 18 | 59 | |
| 19 | 149 | |
| 20 | Radioimmunoassay for Thromboxane B2breakdown → | 166 |
About Elisabeth Granström
Elisabeth Granström is a scholar working on Biochemistry, Pharmacology and Pharmacology, having authored 104 papers that have together received 5.8k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (51 papers), Eicosanoids and Hypertension Pharmacology (23 papers) and Antiplatelet Therapy and Cardiovascular Diseases (11 papers). The work is most often cited by research in Biochemistry (1.1k citations), Pharmacology (2.2k citations) and Equine (123 citations). Elisabeth Granström has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Bengt Samuelsson, H. Kindahl, Mats Hámberg, Sven Hammarström, Curt Malmsten, Marc E. Goldyne, Sven‐Erik Dahlén, Maria Kumlin, T Björck and Barbro Dahlén. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.